Graft vs Host Disease  >>  cyclosporine  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
NCT00195468: Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus

Completed
4
280
RoW
CYCLOSPORINE
Wyeth is now a wholly owned subsidiary of Pfizer
Kidney Failure, Graft vs Host Disease
11/06
11/06
NCT02660684: Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling Donor

Completed
4
39
RoW
Prograf, Tacrolimus, Methotrexate, Cyclosporine
Astellas Pharma Korea, Inc.
Graft Versus Host Disease
02/10
02/10

Download Options